Log In
Print this Print this

BAY 1093884

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionFully human mAb against tissue factor pathway inhibitor (TFPI; LACI)
Molecular Target Tissue factor pathway inhibitor (TFPI) (LACI)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationHemophilia
Indication DetailsTreat hemophilia A
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today